Heart Failure Drugs Flashcards
therapeutic strategies for CHF?
- remove retained salt and water with diuretics
- reduce afterload and salt and water retention with ACE-Is
- reduce excessive sympathetic stimulation with Beta Blockers
- reduce preload or afterload with vasodilators
- directly augment depressed cardiac contractility with positive inotropic drugs
acute heart failure treatment
loop diuretic + prompt acting positive inotropes (beta agonists or PDE inhibitors) + vasodilators
chronic heart failure treatment
diuretics (loops + spironolactone) + ACE-I + Beta blocker (if tolerated)
digitalis if with prominent systolic dysfunction
cardiac glycoside
inhibits Na/K ATPase: increases intracellular Ca, increasing cardiac contractility
used for heart failure, nodal arrhythmias
side effect: NARROW THERAPEUTIC INDEX, ARRHYTHMIAS, VISUAL CHANGES
Digoxin
Digitoxin
also has reduced clearance with quinidine
arrhythmogenesis increased by hypokalemia, hypomagnesemia, hypercalcemia
what drugs have narrow thereapeutic index?
Warfarin Aminoglycosides Lithium Amphotericin B Carbamazepine Phenobarbital Phenytoin Vancomycin Theophylline Digoxin
digitalis toxicity is increased by what states?
hypokalemia, hypomagnesemia, hypercalcemia
treatment of digitalis toxicity
- CORRECT POTASSIUM/MAGNESIUM DEFICIENT
- ANTI-ARRHYTHMIC DRUGS: LIDOCAINE (Phenytoin as alternative)
- DIGOXIN ANTIBODIES (Fab fragments; digibind)
first line therapy for both systolic and diastolic failure
diuretics
diuretic that immediately reduces pulmonary congestion and severe edema associated with acute heart failure
furosemide
diuretics with significant long-term benefits and can reduce mortality in heart failure
spironolactone and eplerenone
first line drugs for chronic heart failure
reduce morbidity and mortality in chronic heart failure
angiotensin antagonists
reduce aldosterone secretion, salt and water retention, and vascular resistance
beta1-selective sympathomimetics apt for acute heart failure, but NOT appropriate for chronic heart failure due to tolerance, lack of oral efficacy, and significant arrhythmogenic effects
Dobutamine (b1 selective) and dopamine
reduce progression of CHRONIC heart failure
beta blockers
carvedilol, labetalol, bisoprolol, nebivolol, metoprolol
increase cAMP by inhibiting its breakdown by phosphodiesterase
increase intracellular Ca, vasodilation
should NOT be used in chronic failure because they increase morbidity and mortality
Phosphodiesterase inhibitors
Inamrinone, Milrinone
drug for acute severe failure with congestion
dramatically effective in CHF due to increased afterload
Nitroprusside or Nitroglycerin